Clinical trial · Observational
Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast Cancer
NCT04068090CI-TRIAL-00044335unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to collect clinical data, blood samples, and self reported symptoms of peripheral neuropathy from Chinese patients with breast cancer after treatment with taxanes. This data will be used to develop predictive markers for neuropathy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood Collection | Other | — | UNRESOLVED |
| Patient Questionnaires | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients with CIPN
- description
- Patients with peripheral neuropathy after treatment with taxanes
- interventionNames
- Other: Patient Questionnaires
- Other: Blood Collection
- label
- Patients without CIPN
- description
- Patients treated with taxanes and don't develop will be enrolled to this cohort and matched to a specified subject with neurotoxicity based on age, tumor stage, chemotherapy regimen or total taxane dosage
- interventionNames
- Other: Patient Questionnaires
- Other: Blood Collection
Primary outcomes (1)
- measure
- Total score from the FACT-GOG-Ntx questionnaire
- timeFrame
- Up to 2 years
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 16 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of breast cancer * Females aged 16 and older * Planning to receive or previous treated with taxanes Exclusion Criteria: * Poorly controlled or insulin-dependent diabetes or other condition likely to predispose to neurotoxicity
References
Publications (0)
Data not yet available
No reference posted for this study.